In this exclusive ISCT TV interview, Marken’s Senior Director, Global Cell and Gene Therapy Operations, Rohin Iyer, PhD, shares how Marken is redefining precision logistics for advanced therapies, including CAR-T cell treatments, with a patient-first approach.

With over 40,000 CAR-T therapies administered to date and the demand for personalized medicine accelerating, the stakes for precision have never been higher. Discover how Marken leverages cutting-edge technology, automation and real-time monitoring to navigate complex global supply chains, mitigate risks and ensure that life-saving therapies reach patients safely, efficiently and without compromise.